The Advancing Innovation in Accelerated Cancer Diagnosis competition, funded by Innovate UK with support from the Office for Life Sciences, supports the clinical validation and evaluation of innovative technologies and devices designed to accelerate cancer diagnosis.
The competition is aimed at developing technologies that can improve the speed and effectiveness of cancer diagnosis and help move promising innovations toward clinical use.
Eligibility Criteria
- Applications must be submitted by collaborations.
- The lead organization must be a UK-registered business, academic institution, or NHS organization.
- The consortium must include at least one UK-registered micro, small, or medium-sized enterprise receiving grant funding.
- Projects must focus on accelerating cancer diagnosis.
- Proposed technologies must be suitable for clinical validation and evaluation. UK Research and Innovation
Funding Details
- Total competition funding: £25.4 million
- Funder: Innovate UK
- Co-funder: Office for Life Sciences
Deadline
- Opening date: September 1, 2026
- Application deadline: October 28, 2026, at 11:00 AM UK time
Further Information
- Applications are submitted through the UK Innovation Funding Service.
- Official Program Page.